K.-H. Shu

636 total citations
38 papers, 493 citations indexed

About

K.-H. Shu is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, K.-H. Shu has authored 38 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Transplantation, 12 papers in Surgery and 9 papers in Nephrology. Recurrent topics in K.-H. Shu's work include Renal Transplantation Outcomes and Treatments (14 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (6 papers). K.-H. Shu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (6 papers). K.-H. Shu collaborates with scholars based in Taiwan, United States and Czechia. K.-H. Shu's co-authors include Ming‐Ju Wu, Mei‐Chin Wen, C.-H. Cheng, Ya‐Wen Chuang, Yuan‐Yow Chiou, Ming‐Jer Tang, Shih‐Ting Huang, Tung‐Min Yu, Cheng‐Hsu Chen and Hao‐Chung Ho and has published in prestigious journals such as Kidney International, Osteoporosis International and Nephrology Dialysis Transplantation.

In The Last Decade

K.-H. Shu

38 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.-H. Shu Taiwan 12 149 144 97 87 85 38 493
Francesca Tinti Italy 13 198 1.3× 135 0.9× 123 1.3× 48 0.6× 65 0.8× 49 662
Calogero Lino Cirami Italy 12 131 0.9× 133 0.9× 84 0.9× 59 0.7× 46 0.5× 37 499
Karine Brochard France 12 248 1.7× 124 0.9× 202 2.1× 96 1.1× 181 2.1× 23 794
Gustavo Martínez-Mier Mexico 12 255 1.7× 48 0.3× 94 1.0× 65 0.7× 78 0.9× 82 569
Birgitta Kranz Germany 15 95 0.6× 311 2.2× 145 1.5× 74 0.9× 126 1.5× 22 618
Sławomir Zmonarski Poland 11 167 1.1× 104 0.7× 183 1.9× 58 0.7× 35 0.4× 42 448
A. Elli Italy 15 124 0.8× 121 0.8× 169 1.7× 141 1.6× 53 0.6× 47 547
Julien Aniort France 10 84 0.6× 164 1.1× 50 0.5× 61 0.7× 83 1.0× 36 379
Eileen W. Tsai United States 14 143 1.0× 129 0.9× 324 3.3× 119 1.4× 99 1.2× 16 647
Johnny Sayegh France 15 205 1.4× 134 0.9× 274 2.8× 163 1.9× 47 0.6× 34 661

Countries citing papers authored by K.-H. Shu

Since Specialization
Citations

This map shows the geographic impact of K.-H. Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-H. Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-H. Shu more than expected).

Fields of papers citing papers by K.-H. Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.-H. Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-H. Shu. The network helps show where K.-H. Shu may publish in the future.

Co-authorship network of co-authors of K.-H. Shu

This figure shows the co-authorship network connecting the top 25 collaborators of K.-H. Shu. A scholar is included among the top collaborators of K.-H. Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.-H. Shu. K.-H. Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chang, Chia‐Hsien, et al.. (2014). Anticancer Benefits of Early Versus Late Use of Rapamycin in a Rat Model of Urothelial Carcinoma. Transplantation Proceedings. 46(4). 1240–1242. 1 indexed citations
3.
Shu, K.-H., Ming‐Ju Wu, C.-H. Cheng, et al.. (2014). Short-Term Prospective Study of Metabolic Syndrome in Renal Transplant Recipients. Transplantation Proceedings. 46(2). 540–542. 4 indexed citations
4.
Shu, K.-H., et al.. (2014). Trend of Outcomes in Renal Transplant Recipients With Hepatitis B Virus: A Longitudinal Analysis Using a National Database. Transplantation Proceedings. 46(2). 578–582. 2 indexed citations
5.
Su, Yu‐Chia, K.-H. Shu, Cheng Hu, et al.. (2014). Serum Endocan Correlated With Stage of Chronic Kidney Disease and Deterioration in Renal Transplant Recipients. Transplantation Proceedings. 46(2). 323–327. 33 indexed citations
6.
Chung, Mu‐Chi, Tung‐Min Yu, K.-H. Shu, et al.. (2014). Influence of Pretransplantation Dialysis Time and Lupus Activity on Outcome of Kidney Transplantation in Systemic Lupus Erythematosus. Transplantation Proceedings. 46(2). 336–338. 11 indexed citations
7.
Chen, Cheng‐Hsu, Ching‐Heng Lin, Mei‐Chin Wen, et al.. (2014). Comparison of Tuberculosis Infection Rates in a National Database of Renal Transplant Patients With Data From a Single Center in Taiwan. Transplantation Proceedings. 46(2). 588–591. 7 indexed citations
8.
Yu, Tung‐Min, Cheng‐Li Lin, K.-H. Shu, et al.. (2014). Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study. Osteoporosis International. 26(2). 785–793. 11 indexed citations
9.
Wu, Minhua, K.-H. Shu, Chung‐Hwan Chen, et al.. (2014). Reduced Variability of Tacrolimus Trough Level in Once-Daily Tacrolimus-Based Taiwanese Kidney Transplant Recipients With High-Expressive Genotype of Cytochrome P450 3A5. Transplantation Proceedings. 46(2). 403–405. 9 indexed citations
10.
Weng, Shuo‐Chun, K.-H. Shu, Der‐Cherng Tarng, et al.. (2014). Uric Acid Is Highly Associated With Kidney Allograft Survival in a Time-Varying Analysis. Transplantation Proceedings. 46(2). 505–510. 12 indexed citations
11.
Wu, Minhua, et al.. (2014). Rapamycin Promotes Podocyte Migration Through the Up-regulation of Urokinase Receptor. Transplantation Proceedings. 46(4). 1226–1228. 3 indexed citations
12.
Shu, K.-H., Hao‐Chung Ho, Ming‐Ju Wu, et al.. (2012). Long-Term Outcomes of Living Kidney Donors Over the Past 28 Years in a Single Center in Taiwan. Transplantation Proceedings. 44(1). 39–42. 11 indexed citations
13.
Huang, Shih‐Ting, K.-H. Shu, C.-H. Cheng, et al.. (2012). Serum Total p-Cresol and Indoxyl Sulfate Correlated With Stage of Chronic Kidney Disease in Renal Transplant Recipients. Transplantation Proceedings. 44(3). 621–624. 36 indexed citations
14.
Su, Yu‐Chia, K.-H. Shu, Cheng Hu, et al.. (2012). Hepatic Stellate Cells Attenuate the Immune Response in Renal Transplant Recipients With Chronic Hepatitis. Transplantation Proceedings. 44(3). 725–729. 5 indexed citations
15.
Shu, K.-H., Yu‐Chia Su, Kai Tang, et al.. (2010). Cotransplantation of Hepatic Stellate Cells Attenuates the Severity of Graft-Versus-Host Disease. Transplantation Proceedings. 42(3). 971–975. 10 indexed citations
16.
Wu, Ming‐Ju, et al.. (2008). Impact of Variability of Sirolimus Trough Level on Chronic Allograft Nephropathy. Transplantation Proceedings. 40(7). 2202–2205. 11 indexed citations
17.
Shu, K.-H., Chi‐Sen Chang, Ya‐Wen Chuang, et al.. (2008). Intestinal bacterial overgrowth in CAPD patients with hypokalaemia. Nephrology Dialysis Transplantation. 24(4). 1289–1292. 20 indexed citations
18.
Chuang, Ya‐Wen, Christopher H.K. Cheng, Shao‐Wen Hung, et al.. (2007). Severe emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and antibiotics. Clinical Nephrology. 68(7). 42–46. 16 indexed citations
19.
Wu, Ming‐Ju, et al.. (2006). Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney International. 69(11). 2029–2036. 146 indexed citations
20.
Wu, Ming‐Ju, et al.. (2004). Sirolimus in chronic allograft nephropathy. Transplantation Proceedings. 36(7). 2053–2055. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Tinti Breakdown of academic impact, for papers by Calogero Lino Cirami Breakdown of academic impact, for papers by Karine Brochard Breakdown of academic impact, for papers by Gustavo Martínez-Mier Breakdown of academic impact, for papers by Birgitta Kranz Breakdown of academic impact, for papers by Sławomir Zmonarski Breakdown of academic impact, for papers by A. Elli Breakdown of academic impact, for papers by Julien Aniort Breakdown of academic impact, for papers by Eileen W. Tsai Breakdown of academic impact, for papers by Johnny Sayegh
Rankless by CCL
2026